Scholarly Index
Anirban Basu
Health Economics and Outcomes Research (United Kingdom); 12,932 total citations; 317 total publications; best world rank #82
Health Economics and Outcomes Research (United Kingdom)
12,932Total citations
317Total publications
46H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Healthcare Policy and Management | Lifetime | 313 | GB 36 | 98.31 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 895 | GB 145 | 98.08 |
| Healthcare cost, quality, practices | Lifetime | 284 | GB 40 | 96.46 |
| Pharmaceutical Economics and Policy | Lifetime | 436 | GB 50 | 95.08 |
| Global Health Care Issues | Lifetime | 749 | GB 127 | 95.25 |
| Advanced Causal Inference Techniques | Lifetime | 172 | GB 19 | 94.90 |
| Statistical Methods in Clinical Trials | Lifetime | 947 | GB 123 | 91.47 |
| Healthcare Policy and Management | 2021-2025 | 82 | GB 4 | 96.29 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 324 | GB 50 | 96.88 |
| Hemoglobinopathies and Related Disorders | 2021-2025 | 112 | GB 6 | 96.45 |
| Iron Metabolism and Disorders | 2021-2025 | 128 | GB 14 | 94.79 |
| Prenatal Screening and Diagnostics | 2021-2025 | 190 | GB 12 | 94.16 |
| Healthcare cost, quality, practices | 2021-2025 | 128 | GB 18 | 91.59 |
| Advanced Causal Inference Techniques | 2021-2025 | 126 | GB 15 | 88.72 |
| Pharmaceutical industry and healthcare | 2021-2025 | 294 | GB 24 | 57.08 |